Keyword: Pear Therapeutics
It wasn't just deals folks were buzzing about in meeting rooms, restaurants and hotel lobbies, as our top FierceBiotech and FiercePharma stories show.
As patients continue taking a more active role in healthcare, pharma's interest in digital therapeutics, already on a roll, will only accelerate.
Novartis and Pear are partnering again, this time in a go-to-market deal for FDA-approved digital products to treat drug abuse.
